Implantable intracardiac device and methods thereof
An implantable intracardiac device to prevent systolic anterior motion of the anterior mitral valve leaflet into the left ventricular outflow tract is described. The device comprises a blocking member configured for implantation within the left ventricle of the heart and in-situ blocking of systolic anterior motion of the mitral valve into the left ventricular outflow tract when anchored into the left ventricle of the heart. The device may be configured for radial expansion from a contracted orientation suitable for transluminal delivery to the left ventricle of the heart within a suitable delivery vehicle and an expanded orientation suitable for deployment within the left ventricle of the heart. The device comprises anchors configured for anchoring the device in-situ within the left ventricle to a wall of the left ventricle.
1. A method of preventing or inhibiting systolic anterior motion of the anterior mitral valve leaflet in a mammal, comprising:
inserting and positioning an implantable intracardiac device, having a blocking member and at least one anchoring element, within the left ventricle of the heart, and at least partially within the left ventricular outflow tract of the mammal; and
coupling the anchoring element to a wall of the left ventricle,
wherein when the intracardiac device is inserted, the blocking member blocks systolic anterior motion of the anterior mitral valve leaflet into the left ventricular outflow tract without re-shaping of the mitral valve annulus.
2. The method of claim 1 , wherein the coupling of the anchoring element includes coupling the anchoring element to the interventricular septum.
3. The method of claim 1 , wherein
the anchoring element is a first anchoring element,
the device further comprises a second anchoring element, and
the method further comprises coupling the second anchoring element to a wall of the left ventricle.
4. The method of claim 1 , wherein
the anchoring element is a first anchoring element disposed on a proximal end of the device,
the device includes a second anchoring element disposed on a distal end of the device, and
the method further comprises coupling the first and second anchoring elements to the interventricular septum of the heart.
5. The method of claim 1 , wherein the implantable intracardiac device is inserted into the left ventricle of the heart percutaneously and transluminally.
6. The method of claim 1 , wherein the implantable intracardiac device is inserted into the left ventricle:
(1) via the right femoral artery and retrogradely across the aortic valve; or
(2) via the right femoral vein and transseptally.
7. The method of claim 1 , wherein the blocking member comprises a coil-shaped body.
8. A method of preventing or inhibiting systolic anterior motion of the anterior mitral valve leaflet in a mammal, comprising:
inserting and positioning an implantable intracardiac device, having a blocking member and at least one anchoring element, within the left ventricle of the heart, and at least partially within the left ventricular outflow tract of the mammal; and
fixing the anchoring element to a wall of the left ventricle,
wherein when the intracardiac device is inserted, the blocking member contacts the anterior mitral valve leaflet during motion of the anterior mitral valve leaflet without re-shaping of the mitral valve annulus.
9. The method of claim 8 , wherein the fixing of the anchoring element includes fixing the anchoring element to the interventricular septum.
10. The method of claim 8 , wherein
the anchoring element is a first anchoring element,
the device further comprises a second anchoring element, and
the method further comprises fixing the second anchoring element to a wall of the left ventricle.
11. The method of claim 8 , wherein
the anchoring element is a first anchoring element disposed on a proximal end of the device,
the device includes a second anchoring element disposed on a distal end of the device, and
the method further comprises fixing the first and second anchoring elements to the interventricular septum of the heart.
12. The method of claim 8 , wherein the implantable intracardiac device is inserted into the left ventricle of the heart percutaneously and transluminally.
13. The method of claim 8 , wherein the implantable intracardiac device is inserted into the left ventricle:
(1) via the right femoral artery and retrogradely across the aortic valve; or
(2) via the right femoral vein and transseptally.
14. The method of claim 8 , wherein the mammal is a human.
15. The method of claim 8 , wherein the blocking member comprises a coil-shaped body.
16. A method of preventing or inhibiting systolic anterior motion of the anterior mitral valve leaflet in a mammal, comprising:
inserting and positioning an implantable intracardiac device, having a blocking member and at least one anchoring element, within the left ventricle of the heart, and at least partially within the left ventricular outflow tract of the mammal; and
fixing the anchoring element into a wall of the interventricular septum,
wherein when the intracardiac device is inserted, the blocking member is located in the path of systolic anterior motion of the anterior mitral valve leaflet in the left ventricular outflow tract, and reduces systolic anterior motion of the anterior mitral valve leaflet without compressing the mitral valve annulus.
17. The method of claim 16 , wherein
the anchoring element is a first anchoring element,
the device further comprises a second anchoring element, and
the method further comprises fixing the second anchoring element to a wall of the left ventricle.
18. The method of claim 16 , wherein
the anchoring element is a first anchoring element disposed on a proximal end of the device,
the device includes a second anchoring element disposed on a distal end of the device, and
the method further comprises coupling the first and second anchoring elements to the interventricular septum of the heart.
19. The method of claim 16 , wherein the blocking member comprises a coil-shaped body.
20. The method of claim 1 , wherein the mammal is:
a mammal suffering from left ventricular outflow tract (LVOT) obstruction,
a mammal suffering from hypertrophic obstructive cardiomyopathy (HOCM),
a mammal who has had mitral valve surgical annuloplasty, or
a mammal having a sigmoid intraventricular septum with symptomatic outflow tract obstruction.
21. The method of claim 8 , wherein the mammal is:
a mammal suffering from left ventricular outflow tract (LVOT) obstruction,
a mammal suffering from hypertrophic obstructive cardiomyopathy (HOCM),
a mammal who has had mitral valve surgical annuloplasty, or
a mammal having a sigmoid intraventricular septum with symptomatic outflow tract obstruction.
22. The method of claim 16 , wherein the mammal is:
a mammal suffering from left ventricular outflow tract (LVOT) obstruction,
a mammal suffering from hypertrophic obstructive cardiomyopathy (HOCM),
a mammal who has had mitral valve surgical annuloplasty, or
a mammal having a sigmoid intraventricular septum with symptomatic outflow tract obstruction.